Basic Information
| LncRNA/CircRNA Name | CTC-501O10.1 |
| Synonyms | NA |
| Region | GRCh38_17:43680273-43705884 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | cell lines (SGC-7901, MGC-803, MKN-45, HGC-27 and GES-1) |
| Expression Pattern | up-regulated |
| Function Description | We identified three lncRNAs, CTC-501O10.1, AC100830.4 and RP11-210K20.5 that were up-regulated in the plasma of GC patients with AUCs 0.724, 0.730 and 0.737, respectively (P < .01). Based on the logistic regression model, the combined AUC of the three lncRNAs was 0.764. The AUC of the panel was 0.700 in the validation cohort. |
| Pubmed ID | 29700972 |
| Year | 2018 |
| Title | A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer |
External Links
| Links for CTC-501O10.1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |